Millions of women suffer in silence with hot flashes -
The sharp decline in the use of hormone therapy has led to a widespread but preventable side effect: millions of women who suffer in silence hot flashes, according to a study by Yale school of medicine researcher and his colleagues.
in the study published in August 27 online edition of the journal Menopause , the team found that moderate to severe hot flashes - also called vasomotor symptoms (VMS) - do are not covered in most women. Women with VMS experience more heat sensation; other symptoms appearing frequently include fatigue, sleep disorders, depression, anxiety, and short-term memory problems.
"Do not treat these symptoms common causes many women to abandon the labor market at a time when their careers are on the rise," said Philip Sarrel, MD, Professor Emeritus in the Departments of Obstetrics , gynecology and reproductive sciences and of psychiatry. "It also places health care requirements and increased insurance costs."
Sarrel and colleagues used data on health insurance compare claims more than 500,000 women, half with and half without hot flashes. the team calculated the costs of health care and lost work over a period of 12 months. the participants were all provided by Fortune 500.
the team found that women who experienced hot flashes were more than 1.5 million healthcare visits than women without hot flashes. the costs for care additional health was $ 339,559,458. The cost of lost work was another $ 27,668,410 during the period of 12-month study.
Hot flashes are the result of the loss of ovarian hormones in the years just before and after natural menopause. For women who have a hysterectomy, symptoms can occur almost immediately after surgery and are usually more severe and long lasting. Over 70% of all postmenopausal women and over 0% of those who underwent hysterectomy experience VMS affecting daily function.
In the past, hot flashes were easily treated with either hormone therapy or other approaches. However, after the publication of results in the Initiative study on the health of women in 02, there was a sharp decline in the use of hormone therapy because of unfounded fears of cancer risks, according Sarrel.
"Women do not talk to their health care providers, and suppliers are not implemented," said Sarrel. "The symptoms can be easily treated in a variety of ways, such as with patches low dose, non-hormonal hormonal drugs, and simple environmental adjustments such as cooling the workplace."
EmoticonEmoticon